InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Burgess Justin, Directeur Comptable Principal. Director active across 1 company, notably Dynavax Technologies CORP. In total, 17 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €107k. Activity tracked since 13 August 2021. The latest transaction was disclosed on 1 March 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
6,666 sharesCommon StockSEC:0001029142-25-000018:0
4,334 shares@ US$11.1210.8% of flowCommon StockSEC:0000950170-24-024970:0
6,667 sharesCommon StockSEC:0001209191-24-003544:0
6,667 sharesCommon StockSEC:0001209191-24-003198:0
8,416 sharesCommon StockSEC:0001209191-24-002915:0
2,528 shares@ US$5.423.0% of flowCommon StockSEC:0001209191-23-044984:0
5,533 shares@ US$9.4111.5% of flowCommon StockSEC:0001209191-23-044984:1
8,061 shares@ US$14.54525.8% of flowCommon StockSEC:0001209191-23-044984:2
3,166 sharesCommon StockSEC:0001209191-23-014204:0
145 shares@ US$10.290.4% of flowCommon StockSEC:0001209191-23-011316:0
10,472 shares@ US$5.4213.5% of flowCommon StockSEC:0001209191-22-045116:0
6,000 sharesCommon StockSEC:0001209191-22-030221:0
133 shares@ US$10.290.8% of flowCommon StockSEC:0001209191-22-016502:0
20,000 shares@ US$3.8115.6% of flowCommon StockSEC:0001209191-21-054799
20,000 shares@ US$3.8144.6% of flowCommon StockSEC:0001209191-21-054799:0
2,500 shares@ US$3.39155.0% of flowCommon StockSEC:0001209191-21-053374:0
2,500 shares@ US$3.39151.8% of flowCommon StockSEC:0001209191-21-053374
17 of 17 declarations
About Burgess Justin
Justin Burgess is the Principal Accounting Officer at Dynavax Technologies Corp. He oversees the company's accounting and financial reporting, ensuring compliance and transparency. His role is essential for maintaining the financial health of Dynavax.
